Sure, it seems as though it was a mistake by IAM, but not one of the fundamentals have changed about the business. The market will do what it will do.
The facts remain the facts:
- NAB trial underway
- Sentry trial also underway and expanded to twice as many practices.
- Further news on the horizon regarding new clients.
Sentry alone will deliver significant revenue should full rollout proceed.
If you can't handle big swings in share price you're at the wrong end of the market.
Ann: Intiger Group - Clarification, page-390
-
- There are more pages in this discussion • 199 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
